
LENZ Therapeutics, Inc.
LENZHealthcare|Biotechnology|US
$3.50
+0.49 (+16.28%)
DCF Value
$2.33
Tangible Book / Share
$6.11
Cash / Share
$6.28
Ownership Breakdown
86.5%
Float
31.4M
Shares Outstanding
27.2M
Float Shares
Major Holders (36)
Combined: 118.2%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BML Investment Partners, L.P. | Partnership | 6.70% | 2,110,727 | Nov 4, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 5.80% | 1,804,099 | Apr 27, 2026 | 13D/G |
| BlackRock Portfolio Management LLC | Holding company | 5.20% | 1,645,489 | Oct 27, 2026 | 13D/G |
| Squarepoint Ops LLC | Investment adviser | 5.10% | 1,593,246 | Apr 8, 2026 | 13D/G |
| Squarepoint (DIFC) Ltd | Investment adviser | 5.10% | 1,593,246 | Apr 8, 2026 | 13D/G |
| Squarepoint Operations Private Limited | Investment adviser | 5.10% | 1,593,246 | Apr 8, 2026 | 13D/G |
| Squarepoint Capital LLP | Investment adviser | 5.10% | 1,593,246 | Apr 8, 2026 | 13D/G |
| Squarepoint Master Fund Limited | Other | 5.10% | 1,590,333 | Apr 8, 2026 | 13D/G |
| Steven A. Cohen | Individual | 4.80% | 1,357,751 | Nov 14, 2025 | 13D/G |
| Senai Asefaw, M.D. | Individual | 3.80% | 1,073,461 | Nov 14, 2025 | 13D/G |
| Paradigm BioCapital Advisors GP LLC | Other | 3.80% | 1,073,461 | Nov 14, 2025 | 13D/G |
| Paradigm BioCapital Advisors LP | Partnership | 3.80% | 1,073,461 | Nov 14, 2025 | 13D/G |
| Israel A. Englander | Individual | 3.70% | 1,159,987 | Oct 21, 2026 | 13D/G |
| Millennium Group Management LLC | Other | 3.70% | 1,159,987 | Oct 21, 2026 | 13D/G |
| Millennium Management LLC | Other | 3.70% | 1,159,987 | Oct 21, 2026 | 13D/G |
| 72 Investment Holdings, LLC | Other | 3.60% | 1,017,751 | Nov 14, 2025 | 13D/G |
| Differentiated Ventures Investments, LLC | Other | 3.60% | 1,017,751 | Nov 14, 2025 | 13D/G |
| Point72 Biotech Private Investments, LLC | Other | 3.60% | 1,017,751 | Nov 14, 2025 | 13D/G |
| Versant Ventures VI GP, L.P. | Partnership | 3.40% | 1,050,599 | Nov 10, 2025 | 13D/G |
| Versant Venture Capital VI, L.P. | Partnership | 3.40% | 1,050,599 | Nov 10, 2025 | 13D/G |
| Versant Ventures VI GP-GP, LLC | Other | 3.40% | 1,050,599 | Nov 10, 2025 | 13D/G |
| Paradigm BioCapital International Fund Ltd. | Corporation | 3.30% | 946,447 | Nov 14, 2025 | 13D/G |
| Versant Vantage II, L.P. | Partnership | 2.70% | 842,162 | Nov 10, 2025 | 13D/G |
| Versant Vantage II GP, L.P. | Partnership | 2.70% | 842,162 | Nov 10, 2025 | 13D/G |
| Versant Vantage II GP-GP, LLC | Other | 2.70% | 842,162 | Nov 10, 2025 | 13D/G |
| Versant Venture Capital VII, L.P. | Partnership | 2.70% | 834,661 | Nov 10, 2025 | 13D/G |
| Versant Ventures VII GP, L.P. | Partnership | 2.70% | 834,661 | Nov 10, 2025 | 13D/G |
| Versant Ventures VII GP-GP, LLC | Other | 2.70% | 834,661 | Nov 10, 2025 | 13D/G |
| Abigail P. Johnson | Individual | 2.00% | 613,374 | Nov 5, 2026 | 13D/G |
| FMR LLC | Holding company | 2.00% | 613,374 | Nov 5, 2026 | 13D/G |
| Point72 Capital Advisors, Inc. | Corporation | 1.20% | 340,000 | Nov 14, 2025 | 13D/G |
| Point72 Asset Management, L.P. | Partnership | 1.20% | 340,000 | Nov 14, 2025 | 13D/G |
| Rajeev Shah | HC, IN | 0.20% | 70,533 | Nov 2, 2026 | 13D/G |
| Peter Kolchinsky | HC, IN | 0.20% | 70,533 | Nov 2, 2026 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 0.20% | 70,533 | Nov 2, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 0.20% | 54,582 | Nov 2, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 871,279 acquired · 1,020,461 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Chevallard Daniel R. | Chief Financial Officer | Oct 30, 2026 | AWARD | 652,063 | $3.05 | $2.0M | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Oct 29, 2026 | SELL | 2,159,516 | $3.36 | $7.3M | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Oct 29, 2026 | SELL | 451,998 | $3.36 | $1.5M | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Oct 29, 2026 | SELL | 107,170 | $3.36 | $360.1K | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Jun 15, 2026 | AWARD | 22,100 | $6.63 | $146.5K | Form 4 |
| George Jeffrey P. | director | Jun 15, 2026 | AWARD | 22,100 | $6.63 | $146.5K | Form 4 |
| Drapkin Kimberlee C | director | Jun 15, 2026 | AWARD | 22,100 | $6.63 | $146.5K | Form 4 |
| MCCOLLUM JAMES W | director | Jun 15, 2026 | AWARD | 22,100 | $6.63 | $146.5K | Form 4 |
| Thunen Shelley B | director | Jun 15, 2026 | AWARD | 22,100 | $6.63 | $146.5K | Form 4 |
| Guerard Frederic | director | Jun 15, 2026 | AWARD | 22,100 | $6.63 | $146.5K | Form 4 |
| Scheiner Zachary | director | Jun 15, 2026 | AWARD | 22,100 | $6.63 | $146.5K | Form 4 |
| George Jeffrey P. | director | Mar 27, 2026 | BUY | 5,592 | $8.92 | $49.9K | Form 4 |
| Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | Mar 27, 2026 | BUY | 28,089 | $8.95 | $251.4K | Form 4 |
| Chevallard Daniel R. | Chief Financial Officer | Mar 27, 2026 | BUY | 7,500 | $8.57 | $64.3K | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Jan 2, 2026 | AWARD | 84,200 | $16.00 | $1.3M | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Jan 2, 2026 | AWARD | 14,000 | — | — | Form 4 |
| Odrich Marc | Chief Medical Officer | Jan 2, 2026 | AWARD | 84,200 | $16.00 | $1.3M | Form 4 |
| Odrich Marc | Chief Medical Officer | Jan 2, 2026 | AWARD | 14,000 | — | — | Form 4 |
| Chevallard Daniel R. | Chief Financial Officer | Jan 2, 2026 | AWARD | 84,200 | $16.00 | $1.3M | Form 4 |
| Chevallard Daniel R. | Chief Financial Officer | Jan 2, 2026 | AWARD | 14,000 | — | — | Form 4 |
| Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | Jan 2, 2026 | AWARD | 358,100 | $16.00 | $5.7M | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Nov 17, 2025 | OPTION EX. | 10,000 | $2.08 | $20.8K | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Nov 17, 2025 | OPTION EX. | 10,000 | $2.08 | $20.8K | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Nov 17, 2025 | SELL | 4,212 | $25.74 | $108.4K | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Nov 17, 2025 | SELL | 5,788 | $26.37 | $152.6K | Form 4 |
| MCCOLLUM JAMES W | director | Nov 7, 2025 | BUY | 10,500 | $22.79 | $239.3K | Form 4 |
| Chevallard Daniel R. | Chief Financial Officer | Nov 7, 2025 | BUY | 2,178 | $22.76 | $49.6K | Form 4 |
| Chevallard Daniel R. | Chief Financial Officer | Nov 7, 2025 | BUY | 20 | $22.71 | $454.20 | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 30, 2025 | SELL | 49,701 | $45.35 | $2.3M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 30, 2025 | SELL | 83,066 | $46.41 | $3.9M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 30, 2025 | SELL | 177 | $47.01 | $8.3K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 30, 2025 | SELL | 34,405 | $45.35 | $1.6M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 30, 2025 | SELL | 57,502 | $46.41 | $2.7M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 30, 2025 | SELL | 123 | $47.01 | $5.8K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 18, 2025 | SELL | 49,479 | $41.59 | $2.1M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 18, 2025 | SELL | 40,907 | $43.00 | $1.8M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 18, 2025 | SELL | 268 | $43.30 | $11.6K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 18, 2025 | SELL | 24,370 | $41.59 | $1.0M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 18, 2025 | SELL | 20,148 | $43.00 | $866.4K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Sep 18, 2025 | SELL | 132 | $43.30 | $5.7K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 22, 2025 | SELL | 20,493 | $40.03 | $820.3K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 22, 2025 | SELL | 5,668 | $40.59 | $230.1K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 25, 2025 | SELL | 50,270 | $39.53 | $2.0M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 25, 2025 | SELL | 2,149 | $39.92 | $85.8K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 26, 2025 | SELL | 43,978 | $38.97 | $1.7M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 26, 2025 | SELL | 3,465 | $39.50 | $136.9K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 22, 2025 | SELL | 10,076 | $40.03 | $403.3K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 22, 2025 | SELL | 2,809 | $40.59 | $114.0K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 25, 2025 | SELL | 24,760 | $39.53 | $978.7K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 25, 2025 | SELL | 1,058 | $39.92 | $42.2K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 26, 2025 | SELL | 21,661 | $38.97 | $844.2K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 26, 2025 | SELL | 1,707 | $39.50 | $67.4K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 15, 2025 | SELL | 145,051 | $39.50 | $5.7M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 18, 2025 | SELL | 30,628 | $38.56 | $1.2M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 15, 2025 | SELL | 69,949 | $39.50 | $2.8M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Aug 18, 2025 | SELL | 15,085 | $38.56 | $581.7K | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Jul 10, 2025 | SELL | 191,376 | $34.00 | $6.5M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Jun 27, 2025 | SELL | 200,000 | $30.46 | $6.1M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Jun 20, 2025 | SELL | 133,924 | $30.25 | $4.1M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Jun 18, 2025 | SELL | 100,000 | $29.95 | $3.0M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Jun 20, 2025 | SELL | 100,877 | $30.35 | $3.1M | Form 4 |
| Versant Venture Capital VI, L.P. | 10 percent owner | Jun 10, 2025 | SELL | 350,000 | $29.00 | $10.2M | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Jun 11, 2025 | AWARD | 13,500 | $30.00 | $405.0K | Form 4 |
| George Jeffrey P. | director | Jun 11, 2025 | AWARD | 13,500 | $30.00 | $405.0K | Form 4 |
| Drapkin Kimberlee C | director | Jun 11, 2025 | AWARD | 13,500 | $30.00 | $405.0K | Form 4 |
| Guerard Frederic | director | Jun 11, 2025 | AWARD | 13,500 | $30.00 | $405.0K | Form 4 |
| Thunen Shelley B | director | Jun 11, 2025 | AWARD | 13,500 | $30.00 | $405.0K | Form 4 |
| MCCOLLUM JAMES W | director | Jun 11, 2025 | AWARD | 13,500 | $30.00 | $405.0K | Form 4 |
| Scheiner Zachary | director | Jun 11, 2025 | AWARD | 13,500 | $30.00 | $405.0K | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Apr 9, 2025 | OPTION EX. | 1,400 | $2.08 | $2.9K | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Apr 9, 2025 | OPTION EX. | 1,400 | $2.08 | $2.9K | Form 4 |
| Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | Mar 7, 2025 | OPTION EX. | 4,200 | $1.04 | $4.4K | Form 4 |
| Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | Mar 7, 2025 | OPTION EX. | 4,200 | $1.04 | $4.4K | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Jan 9, 2025 | AWARD | 80,100 | $26.34 | $2.1M | Form 4 |
| Odrich Marc | Chief Medical Officer | Jan 9, 2025 | AWARD | 80,100 | $26.34 | $2.1M | Form 4 |
| Chevallard Daniel R. | Chief Financial Officer | Jan 9, 2025 | AWARD | 70,444 | $26.34 | $1.9M | Form 4 |
| Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | Jan 9, 2025 | AWARD | 279,100 | $26.34 | $7.4M | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Dec 16, 2024 | OPTION EX. | 3,333 | $2.08 | $6.9K | Form 4 |
| Olsson Shawn | Chief Commercial Officer | Dec 16, 2024 | OPTION EX. | 3,333 | $2.08 | $6.9K | Form 4 |
| Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | Jul 22, 2024 | OPTION EX. | 45,000 | $1.04 | $46.8K | Form 4 |
| Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | Jul 22, 2024 | OPTION EX. | 45,000 | $1.04 | $46.8K | Form 4 |
| Chevallard Daniel R. | Chief Financial Officer | May 14, 2024 | BUY | 3,188 | $15.68 | $50.0K | Form 4 |
| MCCOLLUM JAMES W | director | May 13, 2024 | BUY | 31,332 | $15.99 | $501.1K | Form 4 |
| Alpha Wave Ventures GP, Ltd | 10 percent owner | Mar 21, 2024 | OTHER | 0 | — | — | Form 4 |
| Alpha Wave Ventures GP, Ltd | 10 percent owner | Mar 21, 2024 | OTHER | 0 | — | — | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Mar 21, 2024 | BUY | 933,038 | $15.03 | $14.0M | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Mar 21, 2024 | AWARD | 2,386,301 | — | — | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Mar 21, 2024 | AWARD | 694,755 | — | — | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Mar 21, 2024 | BUY | 64,971 | $15.03 | $976.5K | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Mar 21, 2024 | AWARD | 164,729 | — | — | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Mar 21, 2024 | AWARD | 54,582 | $10.64 | $580.8K | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Mar 21, 2024 | AWARD | 27,000 | $15.05 | $406.4K | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Mar 21, 2024 | AWARD | 10,580 | $10.64 | $112.6K | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Mar 21, 2024 | AWARD | 5,371 | $10.64 | $57.1K | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | Mar 21, 2024 | OTHER | 0 | — | — | Form 4 | |
| Thunen Shelley B | director | Mar 21, 2024 | AWARD | 27,000 | $15.05 | $406.4K | Form 4 |
| MCCOLLUM JAMES W | director | Mar 21, 2024 | AWARD | 16,633 | $15.03 | $250.0K | Form 4 |
| MCCOLLUM JAMES W | director | Mar 21, 2024 | AWARD | 477,600 | — | — | Form 4 |
| MCCOLLUM JAMES W | director | Mar 21, 2024 | AWARD | 95,034 | — | — | Form 4 |
| MCCOLLUM JAMES W | director | Mar 21, 2024 | AWARD | 27,000 | $15.05 | $406.4K | Form 4 |